Latest news
Jazz Pharmaceuticals to Acquire Actio Biosciences in Merger - TipRanksTipRanks · Mon, 10 Aug 2026 22:36:25 GMTJazz Pharma Expands Again in Epilepsy With $820M Actio Bio Acquisition - MedCity NewsMedCity News · Mon, 10 Aug 2026 22:02:41 GMTJazz Pharmaceuticals to acquire Actio Biosciences for up to $1.32bn - Eurasia Business NewsEurasia Business News · Mon, 10 Aug 2026 21:36:11 GMTJazz to buy Actio for up to $1.3B, gaining epilepsy asset - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 19:37:19 GMTTeledyne Technologies Acquires Varex Imaging in $1.1 Billion Deal - Eurasia Business NewsEurasia Business News · Mon, 10 Aug 2026 19:24:11 GMTPoint2 collects $60M, Bernhard's $1B Bowman buy, Jazz's $820M epilepsy deal - AxiosAxios · Mon, 10 Aug 2026 19:23:51 GMT$1.32 Billion for a Molecule: Jazz Pharmaceuticals Bets on Rare-Epilepsy Drug With No Approved Rivals - USA HeraldUSA Herald · Mon, 10 Aug 2026 19:01:18 GMTJazz Pharmaceuticals Strikes $820 Million Deal for Actio Biosciences to Secure First-in-Class Rare Epilepsy Drug - finance.biggo.comfinance.biggo.com · Mon, 10 Aug 2026 18:22:00 GMT